Free Trial
OTCMKTS:CYDY

CytoDyn (CYDY) Stock Price, News & Analysis

CytoDyn logo
$0.29 0.00 (-1.15%)
As of 08/1/2025 03:59 PM Eastern

About CytoDyn Stock (OTCMKTS:CYDY)

Key Stats

Today's Range
$0.29
$0.30
50-Day Range
$0.26
$0.36
52-Week Range
$0.10
$0.49
Volume
887,595 shs
Average Volume
1.20 million shs
Market Capitalization
$366.90 million
P/E Ratio
29.29
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

CytoDyn Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
4th Percentile Overall Score

CYDY MarketRank™: 

CytoDyn scored higher than 4% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for CytoDyn.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of CytoDyn is 29.29, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 28.12.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of CytoDyn is 29.29, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.93.

  • Read more about CytoDyn's valuation and earnings.
  • Percentage of Shares Shorted

    3.02% of the outstanding shares of CytoDyn have been sold short.
  • Short Interest Ratio / Days to Cover

    CytoDyn has a short interest ratio ("days to cover") of 11.8, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in CytoDyn has recently increased by 3.76%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    CytoDyn does not currently pay a dividend.

  • Dividend Growth

    CytoDyn does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.02% of the outstanding shares of CytoDyn have been sold short.
  • Short Interest Ratio / Days to Cover

    CytoDyn has a short interest ratio ("days to cover") of 11.8, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in CytoDyn has recently increased by 3.76%, indicating that investor sentiment is decreasing.
  • News Sentiment

    CytoDyn has a news sentiment score of 1.34. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.45 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for CytoDyn this week, compared to 1 article on an average week.
  • Search Interest

    1 people have searched for CYDY on MarketBeat in the last 30 days.
  • MarketBeat Follows

    6 people have added CytoDyn to their MarketBeat watchlist in the last 30 days. This is an increase of 500% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, CytoDyn insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.54% of the stock of CytoDyn is held by insiders.

  • Percentage Held by Institutions

    Only 5.06% of the stock of CytoDyn is held by institutions.

  • Read more about CytoDyn's insider trading history.
Receive CYDY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CytoDyn and its competitors with MarketBeat's FREE daily newsletter.

CYDY Stock News Headlines

Digital Dollar Alert: Protect Your Wealth Before It’s Too Late
134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts warn a programmable dollar could erase your privacy and control your spending. A free guide reveals how to protect your savings before the system goes live.
CytoDyn Releases ESMO Breast Cancer Meeting Poster
See More Headlines

CYDY Stock Analysis - Frequently Asked Questions

CytoDyn's stock was trading at $0.1097 at the start of the year. Since then, CYDY shares have increased by 166.7% and is now trading at $0.2926.

CytoDyn Inc. (OTCMKTS:CYDY) announced its quarterly earnings results on Friday, July, 25th. The biotechnology company reported ($0.01) EPS for the quarter.

Shares of CYDY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that CytoDyn investors own include American Water Works (AWK), Waste Connections (WCN), The RMR Group (RMR), Voyager Therapeutics (VYGR), DiamondRock Hospitality (DRH), AU Optronics (AUOTY) and iShares Micro-Cap ETF (IWC).

Company Calendar

Last Earnings
7/25/2025
Today
8/02/2025
Next Earnings (Estimated)
8/13/2025
Fiscal Year End
5/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:CYDY
Previous Symbol
NASDAQ:CYDY
CIK
1175680
Fax
N/A
Employees
20
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$0.01
Trailing P/E Ratio
29.29
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$3.74 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-4.40%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.25
Quick Ratio
0.30

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
$0.00 per share
Price / Cash Flow
87.82
Book Value
($0.08) per share
Price / Book
-3.66

Miscellaneous

Outstanding Shares
1,253,930,000
Free Float
1,247,160,000
Market Cap
$366.90 million
Optionable
Not Optionable
Beta
1.23

Social Links

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (OTCMKTS:CYDY) was last updated on 8/3/2025 by MarketBeat.com Staff
From Our Partners